{
  "id": "mhgap#management_b3f399c1",
  "content": "– Levels may be increased by antimalarials including quinine.\nFLUPHENAZINE Start 12.5 mg. Common: sedation, dizziness, blurred vision, dry mouth, Contraindications: impaired consciousness, parkinsonism.\ndepot/long-acting Use 12.5-50 mg every 2-4 weeks. urinary retention, constipation, tachycardia.\nRoute: i.m. in gluteal region. Caution in patients with: cardiac disease, kidney disease, liver disease.\nSerious: orthostatic hypotension, syncope, EPS, Use with caution in older adults.\nAvoid in women who are pregnant/ photosensitivity, weight gain,galactorrhea, amenorrhea,\nbreastfeeding. sexual dysfunction, priapism, NMS, agranulocytosis, Drug-drug interactions:\njaundice. – Increases effects of blood pressure lowering medications.\nDo not use in children/adolescents. – Can lower blood pressure if used with epinephrine.\nTABLE 2: Anticholinergic medications\n(for treatment of extrapyramidal side effects (EPS) Avoid in women who are pregnant or breastfeeding if possible.\nMEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nBIPERIDEN Start 1 mg twice daily. Common: sedation, confusion and memory Caution in patients with: cardiac, liver, or kidney disease.\nIncrease to 3-12 mg daily. disturbance (especially in older adults), tachycardia, dry\nDrug-drug interactions: Caution when combining with other\nRoute: p.o or intravenous (i.v.). mouth, urinary retention and constipation.\nanticholinergic medications.\nTRIHEXYPHENIDYL Start 1 mg daily. Rarely, angle-closure glaucoma, myasthenia gravis and",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Management – Levels may be increased by antimalarials including quinine.\nFLUPHENAZINE Start 12.5 mg. Common: sedation, dizziness, blurred vision, dry mouth, Contraindications: impaired consciousness, parkinsonism.\ndepot/long-acting Use 12.5-50 mg every 2-4 weeks. urinary retention, constipation, tachycardia.\nRoute: i.m. in gluteal region. Caution in patients with: cardiac disease, kidney disease, liver disease.\nSerious: orthostatic hypotension, syncope, EPS, Use with caution in older adults.\nAvoid in women who are pregnant/ photosensitivity, weight gain,galactorrhea, amenorrhea,\nbreastfeeding. sexual dysfunction, priapism, NMS, agranulocytosis, Drug-drug interactions:\njaundice. – Increases effects of blood pressure lowering medications.\nDo not use in children/adolescents. – Can lower blood pressure if used with epinephrine.\nTABLE 2: Anticholinergic medications\n(for treatment of extrapyramidal side effects (EPS) Avoid in women who are pregnant or breastfeeding if possible.\nMEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nBIPERIDEN Start 1 mg twice daily. Common: sedation, confusion and memory Caution in patients with: cardiac, liver, or kidney disease.\nIncrease to 3-12 mg daily. disturbance (especially in older adults), tachycardia, dry\nDrug-drug interactions: Caution when combining with other\nRoute: p.o or intravenous (i.v.). mouth, urinary retention and constipation.\nanticholinergic medications.\nTRIHEXYPHENIDYL Start 1 mg daily. Rarely, angle-closure glaucoma, myasthenia gravis and – levels may be increased by antimalarials including quinine. fluphenazine start 12.5 mg."
}